Αρχειοθήκη ιστολογίου

Τρίτη 20 Νοεμβρίου 2018

Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy

Maurer, MS; Schwartz, JH; Gundapaneni, B; Elliott, PM; Merlini, G; Waddington-Cruz, M; Kristen, AV; ... Rapezzi, C; + view all Maurer, MS; Schwartz, JH; Gundapaneni, B; Elliott, PM; Merlini, G; Waddington-Cruz, M; Kristen, AV; Grogan, M; Witteles, R; Damy, T; Drachman, BM; Shah, SJ; Hanna, M; Judge, DP; Barsdorf, AI; Huber, P; Patterson, TA; Riley, S; Schumacher, J; Stewart, M; Sultan, MB; Rapezzi, C; - view fewer (2018) Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. The New England Journal of Medicine , 379 (11) pp. 1007-1016. 10.1056/NEJMoa1805689 .

https://ift.tt/2qTE11s

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου